Marksans Pharma Limited (BOM:524404)
305.20
+5.30 (1.77%)
At close: Oct 28, 2026
Marksans Pharma Employees
Marksans Pharma had 1,685 employees as of March 31, 2026. The number of employees decreased by 155 or 8.42% compared to the previous year.
Employees
1,685
Change (1Y)
-155
Growth (1Y)
-8.42%
Revenue / Employee
18.82M INR
Profits / Employee
3.07M INR
Market Cap
138.31B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 1,685 | -155 | -8.42% |
| Mar 31, 2025 | 1,840 | 699 | 61.26% |
| Mar 31, 2024 | 1,141 | 289 | 33.92% |
| Mar 31, 2023 | 852 | -38 | -4.27% |
| Mar 31, 2022 | 890 | -248 | -21.79% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CORONA Remedies | 5,153 |
| Marksans Pharma | 1,685 |
| SMS Pharmaceuticals | 1,617 |
| Rubicon Research | 1,290 |
| Pfizer | 1,244 |
| Sanofi Consumer Healthcare India | 597 |
| Senores Pharmaceuticals | 368 |
| Sai Parenteral's | 293 |
Marksans Pharma News
- 2 months ago - Marksans Pharma Transcript: Q1 26/27 - Transcripts
- 2 months ago - Marksans Pharma Quarterly report: Q1 2027 - Filings
- 2 months ago - Marksans Pharma Slides: Q1 2027 - Filings
- 3 months ago - Marksans Pharma to acquire ABCnow GmbH for €892,384 - Business Upturn
- 3 months ago - Marksans Pharma announces ₹0.90 per share final dividend for FY26 - Business Upturn
- 3 months ago - Marksans Pharma announces 90% final dividend ahead of AGM - Business Upturn
- 4 months ago - Marksans Pharma submits machine-readable financial results for March 2026 - Business Upturn
- 4 months ago - Marksans Pharma launches campaign to prevent transfer of unclaimed dividends - Business Upturn